icon
Treatments
Programmeicon
How it works
Treatments, coaching and habit change programme
Coaching
The support of a dedicated health coach
Voy app
Track your progress whilst creating healthy sustainable habits
Results
About
Experts
Resourcesicon
Guides & tips
Tools and tips for lasting weight loss
Research & science
Evidence-based insights and clinical research
icon
icon
menu-close
OVERVIEW
Treatments
icon
How it works
icon
Coaching
icon
Voy app
icon
EXPLORE
Results
icon
About
icon
Experts
icon
Resources
icon
ACCOUNT
Login
icon
GET IN TOUCH
020 3912 9885
Mon-Fri 9:00-17:30
icon
Guides & tips
icon
Research & science
icon
Home/Guides & Tips/Medications/

Retatrutide dosage guide

Retatrutide dosage guide for weight loss

Retatrutide, a weekly weight loss injection, isn’t approved yet, but here’s what we know right now about the dosing schedule for this experimental treatment.

clinician image

Medically reviewed by

Dr Earim Chaudry (MBBS), Chief Medical Officer

iconPublished 3rd June 2025
Research-Based Guide
Table of contents
  • What is retatrutide?
  • Retatrutide dosing schedule
  • Why do I need to follow a reta...
  • What is the retatrutide mainte...
  • Your weight loss journey

Going by the clinical trial results we have so far, retatrutide may be the most effective weight loss medicine yet. After 48 weeks on retatrutide, people lost up to 24.2% of their body weight. On Mounjaro, the mean loss after 88 weeks was 25.3% (although these studies had different sample sizes, so it’s difficult to compare like for like).

Unlike Mounjaro though, retatrutide is an experimental treatment that’s yet to be approved. We’re still learning about how it affects the body—and we don’t know what doses it will be available in.

This last point is important. Dosing schedules are carefully chosen to ensure that the medicine is effective without causing unmanageable side effects. Clinical research is ongoing, but here’s what we know so far about retatrutide dosing for weight loss.

What is retatrutide?

Retatrutide is a new weekly weight loss injection that’s in development. Like Saxenda, Wegovy and Mounjaro, it makes you feel full so you eat less.

Though it works in a unique way. Saxenda and Wegovy—which use the active ingredients liraglutide and semaglutide, respectively—act like the natural hunger hormone GLP-1, while Mounjaro (tirzepatide) mimics the behaviour of GLP-1 as well as another hormone, GIP.

But retatrutide brings on the effects of three hormones: GLP-1, GIP, and GCG (aka glucagon). This triple effect suggests that it’s the most potent medicine of the bunch. Though we’re yet to see any research comparing it to currently available medicines head-to-head.

FYI: retatrutide is also being studied as a type 2 diabetes treatment.

Retatrutide dosing schedule

There’s no official schedule just yet—which means that we can’t give you a retatrutide dosage chart (sorry). But per clinical research, it looks like you would start retatrutide on a lower dose and gradually be moved up, just like with other weight loss injections. 

In a phase II trial, people were put in groups and assigned to different doses. A total of five retatrutide weekly doses were used in the study: 1mg, 2mg, 4mg, 8mg and 12mg.

For those who were due to receive retatrutide doses of 4mg or higher, they started on a lower strength and were gradually dialled up every four weeks, for up to 12 weeks. Most people started on 1mg or 2mg.

Why do I need to follow a retatrutide dosing schedule?

If you were new to running, would you attempt to run a marathon right away? Of course not. You would need to train your body by gradually running longer distances, until you were ready to tackle 26.2 miles.

It’s the same principle with retatrutide. You start on a lower dose so your body can adjust to the medicine—and then handle higher strengths down the line. This helps to reduce your risk of side effects.

What is the retatrutide maintenance dose?

We can’t say just yet. Because clinical research is still going on, we don’t know which doses of retatrutide will be available—let alone which would be the typical weight loss maintenance dose.

But in the phase II trial we mentioned earlier, some people were on a 12mg maintenance dose.

The maintenance dose is the strength of a medicine where it’s working like it’s supposed to without causing troublesome side effects. And because people can respond differently to a medicine, that dose might vary from person to person. Your provider will confirm what your maintenance dose is.

Your weight loss journey

Retatrutide isn’t due to hit the UK market until at least mid-2026. Yet there’s a bunch of other weight loss medications available right now that could help you reach your goals.

Weight Loss Medications
Learn more about other weight loss treatments to make an informed decision.
icon
Science backed programme
icon
Personalised support
icon
Trusted by 65,000 customers across the UK

You can get them posted to you each month when you sign up for our weight loss programme. Our dedicated team of clinicians and coaches will also work with you to transform your lifestyle—while cheering you on all the way.

Take our short quiz to find out if you’re eligible. We’ll review your results and come back to you within minutes.

Looking to start you weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
FAQ

FAQs about retatrutide dosage

Dr Earim Chaudry, MBBS
DisclaimerAt Voy, we ensure that everything you read in our blog is medically reviewed and approved. However, the information provided is not meant to replace professional medical advice, diagnosis, or treatment. It should not be relied upon for specific medical advice.
References
icon¹

Aronne, Louis J et al. “Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial.” JAMAscribble-underline vol. 331,1 (2024): 38-48. doi:10.1001/jama.2023.24945Aronne, Louis J, et al. “Continued Treatment With Tirzepatide For Maintenance Of Weight Reduction In Adults With Obesity: The SURMOUNT-4 Randomised Clinical Trial.” JAMAscribble-underline, vol. 331, no. 1, 2024:38-48. https://jamanetwork.com/journals/jama/fullarticle/2812936.

icon²

Doggrell, Sheila A. “Retatrutide Showing Promise In Obesity (And Type 2 Diabetes).” Expert Opinion on Investigational Drugsscribble-underline, vol. 32, issue 11, 2023:997-1001 https://www.tandfonline.com/doi/10.1080/13543784.2023.2283020.

icon³

Jastreboff, Ania M., et al. “Triple-hormone-receptor Agonist Retatrutide For Obesity—A Phase 2 Trial.” The New England Journal of Medicinescribble-underline, vol. 389, no. 6, 2023:514-526 https://www.nejm.org/doi/full/10.1056/NEJMoa2301972.

icon⁴

Naeem, Muhammad, et al. “Unleashing The Power Of Retatrutide: A Possible Triumph Over Obesity And Overweight: A Correspondence.” Health Science Reportsscribble-underline, vol. 7, no. 2, 2024:e1864 https://pmc.ncbi.nlm.nih.gov/articles/PMC10844714/.

icon⁵

Pasqualotto, Eric, et al. “Effects of Once-weekly Subcutaneous Retatrutide On Weight And Metabolic Markers: A Systematic Review And Meta-analysis of Randomized Controlled Trials.” Metabolism Openscribble-underline, vol. 24, 2024:100321 https://www.sciencedirect.com/science/article/pii/S2589936824000537?via%3Dihub.

card-image
Medication
Retatrutide, tirzepatide, or semaglutide?
Wondering how different weight loss medicines stack up? Here’s a head-to-head comparison of retatrutide vs tirzepatide vs semaglutide.
card-image
Medication
How tirzepatide works
Tirzepatide is the active ingredient in Mounjaro weight loss injections. Here’s how it works to drive powerful results.
card-image
Medication
Amycretin for weight loss
Here’s what we know so far about Amycretin, an experimental weight loss tablet.
card-image
Medication
Retatrutide for weight loss treatment
Retatrutide is an experimental weight loss treatment. Here’s what clinical research currently shows about how effective it is.
Have a question?
Whatever it is, get in touch:
message
020 3912 9885Mon-Fri 9:00-17:00
message
help@joinvoy.comWe aim to reply in 24hrs
Mon-Fri 9:00-17:00
We aim to reply in 24hrs
Our services are not intended for use in a medical emergency. If you need urgent medical attention, please call 111 or 999

PROGRAMME

  • How it works
  • Treatments
  • Coaching
  • The Voy app

VOY

  • Results
  • About
  • Our medical experts

HELP

  • Help Centre (FAQ)
logo
Privacy PolicyTerms & Conditions
Terms of SaleComplaints
Pharmacies: Manual Pharmacy
Superintendent Pharmacist
Vinisha Kanda
GPhC Registration: 2203475
Copyright 2025 Voy™. All rights reserved.
cards
pharmacy-contact
Privacy Preference Center
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below. The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can choose to enable or disable some or all of these cookies but disabling some of them may affect your browsing experience.
Manage Consent Preferences
icon
Necessary Cookies
Always Active
Necessary cookies ensure the basic functionalities of the website, such as security, network management, and accessibility. These cookies cannot be disabled and do not store personal information.
icon
Preferences Cookies
Preferences cookies allow the website to remember information that changes the way the site behaves or looks, such as your preferred language or region.
icon
Statistics Cookies
Statistics cookies help us understand how visitors interact with the website by collecting and reporting information anonymously. These cookies provide insights into metrics such as page visits and traffic sources.
icon
Marketing Cookies
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and more valuable to publishers and third-party advertisers.